Omada Health, Inc. Marketing and Advertising Expense
Omada Health, Inc. (OMDA) reported Marketing and Advertising Expense of $600.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:MarketingAndAdvertisingExpense · last filed 2026-03-06
- Omada Health, Inc. marketing and advertising expense for fiscal 2025 was $600.00K, a 20.00% increase from fiscal 2024.
- Omada Health, Inc. marketing and advertising expense for fiscal 2024 was $500.00K, a 37.50% decline from fiscal 2023.
- Omada Health, Inc. marketing and advertising expense for fiscal 2023 was $800.00K.
| Period end | Marketing and Advertising Expense 12 month |
|---|---|
| 2025-12-31 | $600.00K 10-K · filed 2026-03-06 |
| 2024-12-31 | $500.00K 10-K · filed 2026-03-06 |
| 2023-12-31 | $800.00K 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |